These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9734555)

  • 1. Pilot study of the cytochrome P450-2D6 genotype in a psychiatric state hospital.
    de Leon J; Barnhill J; Rogers T; Boyle J; Chou WH; Wedlund PJ
    Am J Psychiatry; 1998 Sep; 155(9):1278-80. PubMed ID: 9734555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness.
    Chou WH; Yan FX; de Leon J; Barnhill J; Rogers T; Cronin M; Pho M; Xiao V; Ryder TB; Liu WW; Teiling C; Wedlund PJ
    J Clin Psychopharmacol; 2000 Apr; 20(2):246-51. PubMed ID: 10770465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of cytochrome P450-2D6 genotype on the use and interpretation of therapeutic drug monitoring in long-stay patients treated with antidepressant and antipsychotic drugs in daily psychiatric practice.
    Mulder H; Herder A; Wilmink FW; Tamminga WJ; Belitser SV; Egberts AC
    Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):107-14. PubMed ID: 16294366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between cytochrome P450 2D6 genotype and prescription patterns of antipsychotic and antidepressant drugs in hospitalized psychiatric patients: a retrospective follow-up study.
    Mulder H; Wilmink FW; Beumer TL; Tamminga WJ; Jedema JN; Egberts AC
    J Clin Psychopharmacol; 2005 Apr; 25(2):188-91. PubMed ID: 15738755
    [No Abstract]   [Full Text] [Related]  

  • 5. A pilot study on risperidone metabolism: the role of cytochromes P450 2D6 and 3A.
    Bork JA; Rogers T; Wedlund PJ; de Leon J
    J Clin Psychiatry; 1999 Jul; 60(7):469-76. PubMed ID: 10453802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of patients using drugs metabolized by cytochrome P450 2D6 in different populations: a cross-sectional study.
    Mulder H; Heerdink ER; van Iersel EE; Wilmink FW; Egberts AC
    Ann Pharmacother; 2007 Mar; 41(3):408-13. PubMed ID: 17341534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2D6 genotypes in Puerto Rican psychiatry patients with intolerance of antidepressants and antipsychotics.
    Gonzalez-Tejera GM; Corey S
    Bol Asoc Med P R; 2009; 101(1):7-12. PubMed ID: 19954080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.
    Zhou SF
    Clin Pharmacokinet; 2009; 48(12):761-804. PubMed ID: 19902987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2D6 genetic variation in healthy adults and psychiatric African-American subjects: implications for clinical practice and genetic testing.
    Cai WM; Nikoloff DM; Pan RM; de Leon J; Fanti P; Fairchild M; Koch WH; Wedlund PJ
    Pharmacogenomics J; 2006; 6(5):343-50. PubMed ID: 16550211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of Cytochrome P450 Enzymes in American Indian and Caucasian Children Admitted to a Psychiatric Hospital.
    McGrane IR; Loveland JG
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):395-9. PubMed ID: 26871369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation.
    de Leon J; Susce MT; Pan RM; Fairchild M; Koch WH; Wedlund PJ
    J Clin Psychiatry; 2005 Jan; 66(1):15-27. PubMed ID: 15669884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extrapyramidal side effects of neuroleptic and antidepressant treatment: assessment of potential risk factors through CYP2D6 genetic polymorphism].
    Reggiani K; Vandel P; Haffen E; Sechter D; Bizouard P; Vandel S
    Encephale; 2000; 26(1):62-7. PubMed ID: 10875063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is pharmacogenetic CYP2D6 testing useful?
    Vetti HH; Molven A; Eliassen AK; Steen VM
    Tidsskr Nor Laegeforen; 2010 Nov; 130(22):2224-8. PubMed ID: 21109842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2D6 mutations and therapeutic outcome in schizophrenic patients.
    Hamelin BA; Dorson PG; Pabis D; Still D; Bouchard RH; Pourcher E; Rail J; Turgeon J; Crismon ML
    Pharmacotherapy; 1999 Sep; 19(9):1057-63. PubMed ID: 10610012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphism of CYP2D6 and CYP2C19 in east- and southern African populations including psychiatric patients.
    Dandara C; Masimirembwa CM; Magimba A; Sayi J; Kaaya S; Sommers DK; Snyman JR; Hasler JA
    Eur J Clin Pharmacol; 2001 Apr; 57(1):11-7. PubMed ID: 11372584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2D6 genotyping for psychiatric patients treated with risperidone: considerations for cost-effectiveness studies.
    Rodríguez-Antona C; Gurwitz D; de Leon J; Llerena A; Kirchheiner J; de Mesa EG; Ibarreta D
    Pharmacogenomics; 2009 Apr; 10(4):685-99. PubMed ID: 19374522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2D6 and CYP2C19 genotyping in psychiatric patients on psychotropic medication in the former Dutch Antilles.
    Koopmans AB; Vinkers DJ; Gelan PJ; Hoek HW; van Harten PN
    Pharmacogenomics; 2017 Jul; 18(10):1003-1012. PubMed ID: 28639468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2D6 phenotype prediction from genotype: which system is the best?
    Kirchheiner J
    Clin Pharmacol Ther; 2008 Feb; 83(2):225-7. PubMed ID: 18202689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 2D6 polymorphism and its impact on decision-making in psychopharmacotherapy: finding the right way in an ultrarapid metabolizing patient.
    Paulzen M; Tauber SC; Kirner-Veselinovic A; Gründer G
    J Clin Psychiatry; 2011 Nov; 72(11):1465-7. PubMed ID: 22127193
    [No Abstract]   [Full Text] [Related]  

  • 20. DNA microarray technology in the clinical environment: the AmpliChip CYP450 test for CYP2D6 and CYP2C19 genotyping.
    de Leon J; Susce MT; Johnson M; Hardin M; Maw L; Shao A; Allen AC; Chiafari FA; Hillman G; Nikoloff DM
    CNS Spectr; 2009 Jan; 14(1):19-34. PubMed ID: 19169185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.